-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Kestra Medical Techs, Raises Price Target to $30

Benzinga·12/12/2025 14:42:35
Listen to the news
Piper Sandler analyst Matt O'Brien maintains Kestra Medical Techs (NASDAQ:KMTS) with a Overweight and raises the price target from $27 to $30.